Learn / LKFT
NASDAQ: LKFT
Lakefront Biotherapeutics NV (LKFT) stock, explained like you're 5
Lakefront Biotherapeutics NV trades on the Nasdaq under the ticker LKFT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2 billion dollars.
- Ticker
- LKFT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 2 billion dollars
Is Lakefront Biotherapeutics NV a small, medium or large cap company?
No. Lakefront Biotherapeutics NV is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Lakefront Biotherapeutics NV makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves LKFT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Lakefront Biotherapeutics NV (LKFT.AS) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- An €8M upfront payment isn't the only term in Lakefront (LKFT)'s completed cell therapy sale. (Stock Titan)
- Lakefront Biotherapeutics (LKFT) Sells Early Stage Cell Therapy Assets to Armed Cell Therapeutics (GuruFocus)
- At €26.26 a share, Lakefront Biotherapeutics (LKFT) repurchased 126,322 shares. (Stock Titan)
- Lakefront Biotherapeutics NV (LKFT.AS) stock price, news, quote and history (Yahoo Finance UK)
Follow LKFT in your daily brief
Each trading day at 5 PM ET we post what happened to Lakefront Biotherapeutics NV and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow LKFT
Questions about Lakefront Biotherapeutics NV stock
What does Lakefront Biotherapeutics NV do?
Lakefront Biotherapeutics NV trades on the Nasdaq under the ticker LKFT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2 billion dollars.
What is the ticker symbol for Lakefront Biotherapeutics NV?
Lakefront Biotherapeutics NV trades under the ticker LKFT on the Nasdaq.
What is Lakefront Biotherapeutics NV's market cap?
Lakefront Biotherapeutics NV is a small cap stock with a market cap of about 2 billion dollars.
How does Lakefront Biotherapeutics NV make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves LKFT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow LKFT stock every day?
Add LKFT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.